Network and Systems Biology Scientific Core 3

SC3项目总结 心房颤动（AF）是最常见的心律失常，也是心血管死亡的主要危险因素， 中风由于肥胖和人口年龄的增加，AF的发病率进一步增加， 与AF风险和进展相关。尽管房颤的诊断和治疗取得了重大进展， 临床结果仍然很差，并且自上一次AF药物发现以来已经过去了十多年。的 该PPG应用程序的总体目标是使用基因组和转录组学发现来识别预防性和 房颤的治疗策略，并将其推向临床应用。我们的核心假设是， 增加我们对参与遗传、转录组、代谢和 心房的结构变化将使我们能够确定可能的目标， 战略布局为了帮助项目朝着这些目标前进，网络和系统生物学核心（SC 3） 将负责所有RNA测序数据的处理、分析、整合和网络建模， 包括在本发明中使用和生成的大量和单个核、蛋白质组学、代谢组学和功能测定数据， 四个项目。所有项目都建议广泛使用RNA测序研究，使SC3不可或缺 他们的成功。功能测定数据将主要在SC1和SC2中生成，由 然后发送到SC3进行分析并与RNASeq集成。SC3将与该项目密切合作 领导和人员，以帮助解释和可视化的结果，包括那些从传统的差异 分析以及更先进的网络和系统生物学方法。SC3具有独特的混合， 专业知识和经验，将具有RNA加工和建模技能的人员与具有 网络和系统生物学的重点，连同严格的和可重复的管道实施 将有助于使本项目规划中的四个项目填补知识空白，并在理解方面取得进展 和治疗心房纤颤。SC 3将为围绕以下内容组织的PPG提供两大类服务： 正在分析的数据类型。Aim 1将专注于RNA测序数据的服务，包括先进的 网络和系统生物学方法，而Aim 2也将专注于功能分析数据服务 与RNA数据的整合。

SC3 PROJECT SUMMARY Atrial fibrillation (AF) is the most common arrhythmia and a major risk factor for cardiovascular mortality and stroke. Incidence of AF is further increasing due to the rise in obesity and age of the population, factors closely related to AF risk and progression. Despite significant advances in AF diagnosis and management, treatment and clinical outcomes remain poor and more than a decade has passed since the last AF drug discovery. The overall goal of this PPG application is to use genomic and transcriptomic findings to identify preventative and therapeutic strategies for AF and develop them towards clinical application. Our central hypothesis is that increasing our knowledge about molecular mechanisms involved in genetic, transcriptomic, metabolic and structural changes in the atria will allow us to pinpoint possible targets for safer and more effective therapeutic strategies. To help the projects advance towards these goals, the Network and Systems Biology Core (SC3) will be responsible for the processing, analysis, integration and network modeling of all RNA sequencing data, including bulk and single nuclei, proteomic, metabolomics, and functional assay data used and generated in the four projects. All Projects have proposed extensive use of RNA sequencing studies, making SC3 integral to their success. Functional assay data will be generated primarily in SC1 and SC2 under direction of the Projects and then sent to SC3 for analysis and integration with RNASeq. SC3 will work closely with the project leads and personnel to help interpret and visualize the results including those from traditional differential analyses as well as from more advanced network and systems biology approaches. SC3 has a unique blend of expertise and experience, combining personnel with RNA processing and modeling skills and those with a network and systems biology focus, which together with a rigorous and reproducible pipeline implementation will help enable the four projects in this PPG to fill knowledge gaps and make advances towards understanding and treating atrial fibrillation. SC3 will provide two major groups of services to the PPG organized around the type of data being analyzed. Aim 1 will focus on services for RNA sequencing data, including advanced network and systems biology approaches, while Aim 2 will focus on services for functional assay data as well as integrations with the RNA data.